Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 EUR)

Closing information 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Turnover 45,516 Less Arrow 41,247 More Arrow 47,700
Financial expenses 2,917 Less Arrow 2,507 More Arrow 3,635
Earnings before taxes 479 More Arrow 2,772 Less Arrow -7,964
EBITDA 1,337 More Arrow 4,047 Less Arrow -2,433
Total assets 54,215 Less Arrow 50,107 Less Arrow 47,755
Current assets 41,549 Less Arrow 39,405 Less Arrow 36,336
Current liabilities 46,793 Less Arrow 25,832 Less Arrow 17,892
Equity capital 5,808 Less Arrow 3,828 Less Arrow -3,678
- share capital 1,967 Less Arrow 1,836 More Arrow 1,906
Employees (average) 122 More Arrow 126 More Arrow 128

Financial ratios

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Solvency 10.7% Less Arrow 7.6% Less Arrow -7.7%
Turnover per employee 373 Less Arrow 327 More Arrow 373
Profit as a percentage of turnover 1.1% More Arrow 6.7% Less Arrow -16.7%
Return on assets (ROA) 6.3% More Arrow 10.5% Less Arrow -9.1%
Current ratio 88.8% More Arrow 152.5% More Arrow 203.1%
Return on equity (ROE) 8.2% More Arrow 72.4% More Arrow 216.5%
Change turnover 1,331 Less Arrow -4,707 More Arrow 13,654
Change turnover % 3% Less Arrow -10% More Arrow 40%
Chg. No. of employees -4 More Arrow -2 More Arrow 4
Chg. No. of employees % -3% More Arrow -2% More Arrow 3%

Total value of public sale

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.